Sdiptech’s Shares Offering

Baker McKenzie advised Sdiptech on the deal. Sdiptech AB executed a primary issuance of shares of approximately SEK 506 million (approx. $47.5 million) where the subscription price...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Accelleron’s Spin-off from ABB

Baker McKenzie advised Skandinaviska Enskilda Banken in the deal. Accelleron executed a spin-off from ABB. Skandinaviska Enskilda Banken acted as Issuer Agent of Swedish Depositary Receipts. Accelleron...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Xbrane Biopharma’s Shares Offering

Baker McKenzie advised Xbrane Biopharma on the deal. Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

BioInvent’s Shares Offering

Baker McKenzie acted as legal advisor to Kempen & Co and Pareto Securities on the deal. BioInvent International has carried out a primary issuance of shares...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Abliva’s Shares Offering

Baker McKenzie acted as legal advisor to the banks, while Cirio advised Abliva on the deal. Abliva has carried out a primary issuance of shares of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here